8-144516739-G-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The ENST00000621189.4(RECQL4):c.-692C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,530,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000621189.4 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Publications
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000621189.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | NM_004260.4 | MANE Select | c.380C>T | p.Pro127Leu | missense | Exon 5 of 21 | NP_004251.4 | ||
| RECQL4 | NM_001413023.1 | c.-692C>T | 5_prime_UTR_premature_start_codon_gain | Exon 4 of 19 | NP_001399952.1 | ||||
| RECQL4 | NM_001413041.1 | c.-754C>T | 5_prime_UTR_premature_start_codon_gain | Exon 4 of 19 | NP_001399970.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | ENST00000621189.4 | TSL:1 | c.-692C>T | 5_prime_UTR_premature_start_codon_gain | Exon 4 of 20 | ENSP00000483145.1 | |||
| RECQL4 | ENST00000617875.6 | TSL:1 MANE Select | c.380C>T | p.Pro127Leu | missense | Exon 5 of 21 | ENSP00000482313.2 | ||
| RECQL4 | ENST00000621189.4 | TSL:1 | c.-692C>T | 5_prime_UTR | Exon 4 of 20 | ENSP00000483145.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152206Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000568 AC: 10AN: 176054 AF XY: 0.0000746 show subpopulations
GnomAD4 exome AF: 0.0000131 AC: 18AN: 1377852Hom.: 0 Cov.: 35 AF XY: 0.0000133 AC XY: 9AN XY: 677140 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000131 AC: 20AN: 152324Hom.: 0 Cov.: 34 AF XY: 0.000161 AC XY: 12AN XY: 74492 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.P127L variant (also known as c.380C>T), located in coding exon 5 of the RECQL4 gene, results from a C to T substitution at nucleotide position 380. The proline at codon 127 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis does not support a benign or deleterious effect of this variant on protein structure/function
RECQL4-related disorder Uncertain:1
The RECQL4 c.380C>T variant is predicted to result in the amino acid substitution p.Pro127Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.047% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-145742123-G-A) and is interpreted as uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/239772/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Baller-Gerold syndrome Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 127 of the RECQL4 protein (p.Pro127Leu). This variant is present in population databases (rs550470182, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 239772). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RECQL4 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at